UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2023		24,406,816
Beginning balance at Dec. 31, 2023	$ 1,652,518	$ 244	$ 1,517,650	$ 168,871	$ (34,247)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	5,329		5,329	0
Exercise of stock options (in shares)		2,236
Exercise of stock options	145		145
Issuance of restricted stock, net (in shares)		198,887
Issuance of restricted stock, net	(3,831)	$ 2	(3,833)
Common stock dividends	(14,773)			(14,773)
Foreign currency translation adjustment	(26,650)				(26,650)
Unrealized gains on marketable securities, net of tax	143				143
Net income	29,702			29,702
Ending balance (in shares) at Mar. 31, 2024		24,607,939
Ending balance at Mar. 31, 2024	$ 1,642,583	$ 246	1,519,291	183,800	(60,754)
Beginning balance (in shares) at Dec. 31, 2024	24,502,385	24,502,385
Beginning balance at Dec. 31, 2024	$ 1,662,499	$ 245	1,532,414	218,405	(88,565)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	5,471		5,471
Exercise of stock options (in shares)		762
Exercise of stock options	43		43
Issuance of restricted stock, net (in shares)		149,871
Issuance of restricted stock, net	(9,315)	$ 2	(9,317)
Repurchase of common stock	(33,700)	$ (4)	(25,759)	(7,937)
Repurchase of common stock (in shares)		(391,302)
Common stock dividends	(14,772)			(14,772)
Foreign currency translation adjustment	3,343				3,343
Unrealized gains on marketable securities, net of tax	1				1
Net income	$ 29,744			29,744
Ending balance (in shares) at Mar. 31, 2025	24,261,716	24,261,716
Ending balance at Mar. 31, 2025	$ 1,643,314	$ 243	$ 1,502,852	$ 225,440	$ (85,221)